Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02010333 · ClinicalTrials.gov registry record · Phase 2
A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation
A Phase 2 study of Head Lice Infestation, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
- 2
- Study locations
NCT02010333 is a Phase 2 study of Head Lice Infestation that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 22 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT02010333, a Phase 2 study of Head Lice Infestation, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary purpose of the study is to evaluate safety and tolerability of a single application of Ha44 Gel 0.74% w/w for the treatment of head lice. Secondary purpose is to evaluate PK of Ha44 and benzyl alcohol under conditions of maximal exposure in pediatric population.
Conditions Studied
Interventions
- DRUG Ha44 Gel 0.74% w/w
Study Locations (2)
California
- Universal Biopharma Research Institute - Dinuba
- Axis Clinical Trials - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02010333
The ClinicalTrials.gov registry entry for NCT02010333 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr. Reddy's Laboratories Limited, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Head Lice Infestation appearing as the primary indexed condition, and to 1 intervention - of which Ha44 Gel 0.74% w/w is the first listed.
NCT02010333 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02010333 about?
NCT02010333 is a clinical study titled "A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation". The primary purpose of the study is to evaluate safety and tolerability of a single application of Ha44 Gel 0.74% w/w for the treatment of head lice. Secondary purpose is to evaluate PK of Ha44 and benzyl alcohol under conditions of maximal exposure in pediatric population.
What is the current status of trial NCT02010333?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2013-04. Estimated completion is 2014-08.
What conditions does trial NCT02010333 study?
This clinical trial studies the following conditions: Head Lice Infestation.
What interventions are being tested in trial NCT02010333?
The interventions under investigation include: Ha44 Gel 0.74% w/w (DRUG).
Who is sponsoring clinical trial NCT02010333?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02010333 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.